Plain-English translation of NCT05753137 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing acupuncture as an add-on treatment for people with glaucoma — a condition where pressure builds up inside the eye and can damage vision. Researchers want to see if acupuncture at specific points on the body, combined with your regular glaucoma medications, might help lower eye pressure and improve how you feel. The trial will follow 50 people for 12 weeks to measure changes in eye pressure, vision, and quality of life.
Glaucoma can be hard to control with medications alone, and some patients want additional options to protect their vision. This study explores whether this treatment might offer extra benefit as a complement to standard care.
You will receive acupuncture once a week for 6 weeks, with each session lasting about 20 minutes. Half the participants will receive acupuncture at points related to eye health, while the other half will receive acupuncture at points not related to the eyes (to compare results fairly). During each visit and at the end of 12 weeks, researchers will check your eye pressure, take measurements of your eye structure, test your vision, and ask you questions about your symptoms and quality of life.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Taiwan
Sponsor
China Medical University Hospital
Enrollment target
~50 participants
Started
June 2023
Primary completion
June 2025
Age range
20 Years and older
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
LEE YU-CHEN, Ph.D
China Medical University, China